Lin, C., Hu, F., Chu, H., Ren, P., Ma, S., Wang, J., . . . Ma, S. (2021). The role of EGFR‐TKIs as adjuvant therapy in EGFR mutation‐positive early‐stage NSCLC: A meta‐analysis. Thorac Cancer.

Lin, Chutong, Fengling Hu, Hongling Chu, Peng Ren, Shanwu Ma, Jingdi Wang, Jie Bai, Xuan Han, and Shaohua Ma. "The Role of EGFR‐TKIs As Adjuvant Therapy in EGFR Mutation‐positive Early‐stage NSCLC: A Meta‐analysis." Thorac Cancer 2021.

Lin, Chutong, et al. "The Role of EGFR‐TKIs As Adjuvant Therapy in EGFR Mutation‐positive Early‐stage NSCLC: A Meta‐analysis." Thorac Cancer 2021.